placeholder image
V. N. Shah All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2024
  • Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. 
    Endocrine Reviews. 2023
  • Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2022
  • How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod® 5 System. 
    Diabetes Research and Clinical Practice. 2022
  • Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D exchange. 
    Journal of Diabetes and Its Complications. 2022
  • Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM Study. 
    Journal of Diabetes Science and Technology. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. 
    Diabetes care. 2021
  • Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 
    JAMA. 2020
  • Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. 
    Journal of Clinical Endocrinology and Metabolism. 2019
  • Young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery. 
    Diabetes care. 2019
  • Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. 
    Lancet (London, England). 2018
  • Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol. 
    BMJ open. 2017
  • REPLACE-BG: A randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. 
    Diabetes care. 2017
    • Editorial Article
  • Duration of hybrid closed-loop insulin therapy to achieve representative glycemic outcomes in adults with type 1 diabetes [editorial]. 
    Diabetes care.  43. 2020
    • Conference Poster
  • Autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D Exchange [poster]
    2019
  • Hybrid closed-loop in adults with type 1 diabetes: impact of baseline A1c on glucose outcomes and insulin delivery [poster]
    2019
  • Optimal sampling duration of hybrid closed-loop therapy to determine long-term glycemic control in adults with type 1 diabetes [poster]
    2019
  • Increased HbA1c variability may shorten time to microalbuminuria development in type 1 diabetes (T1D) [poster]
    2018
    • Review
  • Biomarkers for the diagnosis of heart failure in people with diabetes: a consensus report from Diabetes Technology Society [review]. 
    Progress in Cardiovascular Diseases. 2023
    • Contact
    full name
  • V. N. Shah
    • Quick Info
     
    Collaboration